Results 111 to 120 of about 6,192 (194)

Ameliorative effects of Wiryeongtang (herbal medicine) on cardiorenal complications via modulation of inflammatory and fibrotic responses in diabetic mice. [PDF]

Integr Med Res
Yoon JJ, Kim HY, Tai AL, Yang YJ, Park SJ, Lee HS.   +5 more
europepmc   +1 more source

Bioequivalence assessment between two formulations of a film-coated fixed-dose combination of metformin and vildagliptin (850/50mg) in healthy Tunisian subjects under fed conditions. [PDF]

Sci Rep
Ferchichi K, Gaies E, Ben Hammamia S, El Jebari H, Daldoul M, Ghorbel S, Srairi S, Guermazi S, Gorgi Y, Boutiba I, Bouzid K, Abbessi A, Daghfous R, Ben Sassi M, Trabelsi S.   +14 more
europepmc   +1 more source

Evaluation of the therapeutic effect of new hypoglycemic drugs on patients with heart failure with reduced ejection fraction and type 2 diabetes: a systematic review and network meta-analysis. [PDF]

Front Cardiovasc Med
Chen XR, Mao XP, Luo D, Yu CQ, Bai JN.
europepmc   +1 more source

Vildagliptin and Omarigliptin Differentially Bind to DPP-4 Homodimers and Modulate Osteoclast-Mediated Bone Resorption. [PDF]

Compr Physiol
Aeimlapa R, Panmanee J, Teerapornpuntakit J, Wongdee K, Thongbunchoo J, Panupinthu N, Svasti S, Apaijai N, Sa-Nguanmoo P, Chattipakorn S, Chattipakorn N, Charoenphandhu N.   +11 more
europepmc   +1 more source

Preclinical Modeling and Simulation to Explore the Tissue/Plasma Exposure and Pharmacodynamic Effect of Vildagliptin in Diabetes Treatment. [PDF]

CPT Pharmacometrics Syst Pharmacol
Dias BB, Olivo LB, de Araújo BV.
europepmc   +1 more source

Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats.

, 2005
The enzyme dipeptidyl peptidase-IV (DPP-4) inactivates the incretin hormone glucagon-like peptide-1 (GLP-1). Because GLP-1 has therapeutic effects in patients with type 2 diabetes, but its potential is limited by a short half-life, DPP-4 inhibition is a ...
Balkan, Bork, Wang, Pei-Ran, Burkey, Bryan, Li, X, Hughes, Thomas, Bolognese, Lori, Mone, Manisha, Russell, Mary   +7 more
core  

ERRATUM: Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. [PDF]

J Endocrinol
Apaijai N, Inthachai T, Lekawanvijit S, Chattipakorn SC, Chattipakorn N.   +4 more
europepmc   +1 more source

Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan. [PDF]

Drugs Real World Outcomes
Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A.   +4 more
europepmc   +1 more source

Efficacy and safety of novel antidiabetic drugs in patients with type 2 diabetes and chronic kidney disease: a network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Zhu X, Wang X, Zhang P, Yang Z, Zhao N, Li J, Shi Y, Zhao Y, Ma J.   +8 more
europepmc   +1 more source

Surfing the vildagliptin tsunami

Indian Journal of Endocrinology and Metabolism, 2020
openaire   +3 more sources